Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells $336,502.08 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs sold 36,261 shares of the company’s stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the sale, the director now owns 107,706 shares in the company, valued at $999,511.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Viemed Healthcare Stock Performance

VMD stock opened at $9.15 on Thursday. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $10.44. The stock has a market capitalization of $356.30 million, a price-to-earnings ratio of 33.89 and a beta of 1.43. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The stock’s fifty day moving average is $8.31 and its two-hundred day moving average is $7.53.

Viemed Healthcare (NASDAQ:VMD) last posted its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $58.00 million during the quarter.

Institutional Trading of Viemed Healthcare

Large investors have recently added to or reduced their stakes in the business. BBR Partners LLC bought a new position in Viemed Healthcare during the 3rd quarter valued at $110,000. Millrace Asset Group Inc. lifted its position in shares of Viemed Healthcare by 13.3% in the third quarter. Millrace Asset Group Inc. now owns 231,322 shares of the company’s stock worth $1,696,000 after purchasing an additional 27,084 shares in the last quarter. Thrivent Financial for Lutherans grew its stake in Viemed Healthcare by 0.6% in the third quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock valued at $25,110,000 after purchasing an additional 21,047 shares in the last quarter. Bard Associates Inc. boosted its holdings in Viemed Healthcare by 1.1% in the third quarter. Bard Associates Inc. now owns 345,052 shares of the company’s stock worth $2,529,000 after purchasing an additional 3,762 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its position in Viemed Healthcare by 5.6% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock worth $222,000 after acquiring an additional 1,601 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.